Obesity is closely linked to a significantly higher risk of serious long-term diseases – including heart disease, Type 2 diabetes, and certain cancers. A major study published in The Lancet in early 2026 has now added to this picture, finding that people with obesity also face a 70% higher risk of hospitalisation or deaths specifically from infectious disease.

That statistic is striking, but it opens the door to a more useful conversation – one that focuses on understanding why weight gain happens, and what can be done about it in a sustainable, personalised way.

Understanding the factors that contribute towards obesity

Weight gain is often framed as a simple equation of calories in versus calories out. While energy balance does matter, this explanation rarely captures the full picture.

Hormones, metabolism, stress, sleep, and even the health of the gut, all play a role in how the body stores and uses energy. Two people can follow similar diets and exercise routines yet experience very different outcomes. That’s because underlying biology influences how the body responds.

Insulin resistance is one of the most important drivers. When the body becomes less responsive to insulin, it tends to store more fat, particularly around the abdomen. This same process also increases the risk of cardiovascular disease and Type 2 diabetes.

Chronic stress can contribute too. Elevated cortisol levels influence appetite, fat storage, and blood sugar regulation. Poor sleep disrupts hunger hormones, making it harder to regulate food intake. Over time, these factors combine, creating a metabolic environment that promotes weight gain.

Why obesity increases the risk of disease

Adipose tissue, or body fat, isn’t just passively stored. It acts as an active metabolic organ, releasing inflammatory signals and hormones that affect the entire body.

Excess body fat, particularly visceral fat around the organs, is associated with chronic low-grade inflammation. This inflammation plays a key role in the development of atherosclerosis, insulin resistance, and cellular dysfunction.

It also places strain on the cardiovascular system, increases blood pressure, and affects lipid metabolism. Over time, this creates the conditions for heart disease, stroke, and metabolic illness to develop.

The Lancet study found this systemic impact extends to infectious disease too. Researchers followed over 540,000 adults for an average of 13–14 years and found a clear, graded relationship: the higher the BMI, the greater the risk of serious infection. Importantly, this was an observational study and cannot establish causation directly, but the consistency of the finding across bacterial, viral, parasitic, and fungal infections suggests broad biological mechanisms are at work.

This helps explain why the risks associated with obesity go far beyond appearance or mobility. The impact is systemic.

A functional medicine perspective

As a consultant cardiologist and specialist in integrated and holistic health, certified by the Institute for Functional Medicine (IFM), Dr Konrad Grosser focuses on identifying the underlying drivers behind weight gain.

This means looking at factors such as insulin resistance, inflammation, hormone balance, thyroid function, gut health, and lifestyle patterns. It also means understanding how these factors interact, rather than viewing them separately.

A functional medicine approach to weight management is highly individual.

Some people may benefit from improving blood sugar control through balanced macronutrient intake. Others may need to address the health of the gut, reduce inflammation, or correct nutrient deficiencies. Sleep and stress management are also often just as important as dietary changes.

When metabolism becomes more balanced, weight loss tends to follow more naturally, without extreme or short-term measures.

Small changes, long-term impact

One of the most encouraging aspects of a more functional approach is that even modest improvements can have a meaningful effect on health. Improving insulin sensitivity, reducing inflammation, and supporting cardiovascular function can lower the risk of disease, even before significant weight loss occurs.

This shifts the focus from quick results to long-term health. It also makes change feel more achievable. With the right understanding and support, many of the underlying drivers can be addressed.

An integrative consultation with Dr Konrad Grosser offers a more in-depth look at the factors influencing weight and metabolic health, along with a personalised plan to reduce risk and improve long-term wellbeing. Book an appointment today.

Pancreatic cancer is often described as one of the most challenging cancers to treat, typically because it’s usually detected late. Symptoms can be vague, easy to overlook, and by the time a clear diagnosis is made, the disease is often already advanced.

That’s why the NHS has launched a pilot programme focused on identifying people at higher risk much earlier, using subtle warning signs such as a recent diagnosis of Type 2 diabetes and unexplained weight loss. It’s a significant step forward, and it reflects a broader shift in medicine, moving from reactive care to early risk stratification.

Why early detection matters

Pancreatic cancer doesn’t tend to produce obvious symptoms in its early stages. Abdominal discomfort, digestive changes, or weight loss can easily be attributed to other causes. As a result, diagnosis often happens when the cancer has already progressed.

The NHS pilot programme aims to change that by using data and clinical patterns to flag those who may warrant further investigation. Rather than waiting for late-stage symptoms, the focus is on recognising early signals that something may be wrong.

This kind of proactive approach saves lives. The earlier pancreatic cancer is detected, the more treatment options are available and the better the potential outcomes.

The link between new-onset diabetes and pancreatic cancer

One of the most important early warning signs being examined is recently diagnosed Type 2 diabetes. Particularly in those over 50 who have no clear risk factors for diabetes.

A recent review highlighted the complex, bidirectional relationship between pancreatic cancer and diabetes. In some cases, new-onset diabetes may be an early manifestation of pancreatic cancer, rather than simply a coincidence. Tumour-related changes in insulin production and glucose metabolism can appear months, or even years, before other symptoms.

This doesn’t mean that everyone diagnosed with Type 2 diabetes is at risk of pancreatic cancer. However, it reinforces the importance of looking at new metabolic changes in context, particularly when accompanied by unexplained weight loss or other concerning features.

Understanding the wider risk profile

As well as diabetes, several other risk factors are linked to pancreatic cancer. Research has explored the roles of chronic inflammation, obesity, smoking, heavy alcohol use, and long-standing metabolic dysfunction. Family history and certain genetic mutations also increase risk.

Lifestyle factors matter too. Smoking remains one of the strongest modifiable risks. Obesity and central adiposity are linked to chronic low-grade inflammation and insulin resistance, both of which may contribute to pancreatic cellular stress. Poor metabolic health over time places strain not only on the pancreas’ insulin-producing cells, but also on its exocrine function.

These are not isolated risks, they interact. Insulin resistance increases inflammation, chronic inflammation affects cellular repair, and environmental exposures can further compound these effects.

An integrated approach to risk assessment

This is where a more integrated approach becomes valuable. Dr Konrad Grosser routinely evaluates metabolic and inflammatory markers that may signal increased long-term risk, even before disease develops.

At Kent Cardio, assessments often include fasting insulin, HOMA-IR, inflammatory markers, lipid profiling, liver health, and broader metabolic testing. If someone presents with new-onset diabetes or unexplained weight changes, these findings are interpreted in the context of overall risk rather than in isolation.

While no single test predicts pancreatic cancer, a comprehensive view of health helps identify patterns that may warrant closer monitoring or further investigation.

An integrative consultation with Dr Konrad Grosser offers a proactive way to assess these risk factors, address modifiable contributors, and create a personalised prevention strategy.

Kidney disease is often thought of as a late-stage complication of other illnesses, something that appears after years of diabetes or long-standing high blood pressure. However, recent data suggests a more concerning reality. Chronic kidney disease is rising steadily, and many people are developing kidney damage earlier than expected, often without realising it.

Why kidney disease is becoming more common

A major international study published in The Lancet, has revealed a sharp increase in chronic kidney disease worldwide, driven largely by metabolic conditions such as Type 2 diabetes, obesity, and hypertension. These conditions place sustained strain on the kidneys, gradually impairing their ability to filter waste, regulate fluids, and maintain electrolyte balance.

The kidneys are highly sensitive organs. Persistent high blood sugar damages the tiny blood vessels responsible for filtration. Elevated blood pressure increases pressure within the kidney’s delicate structures. Over time, this combination leads to scarring and loss of function.

What’s often overlooked is that kidney disease doesn’t suddenly appear once diabetes or hypertension is diagnosed. It develops slowly, often during years of insulin resistance, inflammation, and metabolic imbalance that precede formal diagnoses. This long lead-in period represents a missed opportunity for prevention.

Metabolic dysfunction and hidden kidney risk

Metabolic dysfunction plays a central role in rising kidney disease rates. Insulin resistance, central obesity, and chronic low-grade inflammation all contribute to kidney stress. Even people with borderline blood sugar or blood pressure readings may already be placing strain on their kidneys without knowing it.

Standard screening often focuses on later-stage markers such as reduced kidney filtration rate. While these tests are essential, they don’t always capture early dysfunction. In the early stages, there are no clear symptoms and by the time it is picked up on a routine test, the damage may already be advanced.

This is why early metabolic screening matters. Identifying insulin resistance, inflammation, and vascular stress early allows intervention before kidney damage becomes irreversible.

How environmental exposure increases the risk

As well as metabolic health, environmental factors are increasingly recognised as contributors to kidney disease. A large review has linked long-term exposure to air pollution and heavy metals with increased risk of chronic kidney disease.

Pollutants such as fine particulate matter, lead, and cadmium can accumulate in the body over time, placing additional stress on the kidneys. These exposures often act alongside metabolic risk factors, compounding damage rather than acting alone.

For people living in urban environments or with occupational exposure, this is another reason to take kidney health seriously.

Why early screening makes such a difference

Kidney disease is far easier to slow, stabilise, or even prevent when identified early. Simple blood and urine tests can detect early changes long before symptoms appear, but only if they’re used proactively.

Early screening helps you to make more informed decisions around nutrition, blood sugar control, blood pressure management, hydration, and medication use. It also provides the opportunity to reduce exposure to environmental stressors where possible.

For Dr Konrad Grosser, kidney health is never assessed in isolation. As an interventional cardiologist with additional training in functional and metabolic medicine, he looks at kidney function alongside cardiovascular health, metabolic markers, inflammation, and hormonal balance.

His assessments often include early markers of kidney strain, alongside metabolic testing such as fasting insulin, inflammatory indicators, and measures of vascular health. Biological age testing can provide additional context around vascular ageing when interpreted alongside established clinical markers.

This integrated approach allows prevention strategies to be personalised. For some, that may mean improving insulin sensitivity and reducing inflammation. For others, it may involve addressing blood pressure variability, reviewing medications, or supporting renal and hepatic clearance mechanisms.

A consultation with Dr Grosser offers the opportunity to assess kidney health as part of a wider, preventative strategy that protects long-term cardiovascular and metabolic health too.

Recent studies suggest that detailed molecular profiling from simple pinprick blood tests could reveal early biological signals linked to conditions such as diabetes, heart disease, dementia, and cancer, up to ten years before symptoms appear.

This reflects a shift that progressive medicine has been moving towards for some time. Rather than waiting for disease to declare itself, the focus is increasingly on understanding health trajectories early and identifying biological stress before irreversible damage occurs.

With his background in integrative and functional medicine, Dr Konrad Grosser is already applying this forward-thinking approach in clinical practice, offering patients advanced biological testing alongside personalised, preventative treatment strategies.

What these studies are really telling us

A large-scale metabolomic project carried out by UK Biobank, involving around half a million volunteers, analysed hundreds of biological markers from very small blood samples. Instead of assessing a handful of isolated values, researchers examined patterns across metabolism, inflammation, immune activity, and cellular function.

When viewed together, these patterns can reveal subtle biological strain long before disease becomes clinically apparent. Changes in glucose handling, lipid metabolism, inflammatory signalling, or protein expression may not cause immediate symptoms, but they can significantly increase long-term risk.

Importantly, the purpose of this data was not simply early diagnosis, but prediction and prevention. The project aims to help researchers better understand the earliest biological changes linked to neurological disease, cardiovascular disease, and cancer, long before traditional screening tools would raise concern.

This represents a fundamental shift in thinking. Instead of asking, “Is there a disease present today?”, a more meaningful question becomes, “What direction is this person’s health heading in if nothing changes?”

Early signals, not early diagnoses

It is important to be clear about what these advanced tests can and cannot do. They are not designed to predict a specific diagnosis with certainty. Instead, they identify biological trajectories.

A useful analogy is maintenance rather than repair. Detecting early strain within a biological system allows intervention while there is still capacity to correct course. Most chronic diseases do not appear suddenly.

Type 2 diabetes develops over years of insulin resistance and metabolic dysfunction. Cardiovascular disease progresses gradually through inflammation, endothelial damage, and vascular ageing. Neurodegenerative conditions often begin with mitochondrial and metabolic changes decades before memory or cognitive symptoms emerge.

By the time symptoms appear, these processes are often well established, and opportunities for prevention are far more limited.

Why standard tests often miss the early warning signs

Further support for this approach comes from a large study published in JAMA Network Open, which showed that measures of biological age based on molecular and physiological markers were more strongly associated with mortality and disease risk than chronological age alone. The researchers found that accelerated biological ageing was closely linked to lifestyle and metabolic factors such as obesity, physical inactivity, smoking, and chronic stress, even when standard clinical measures appeared normal. This reinforces the idea that biological age captures underlying physiological strain earlier than routine testing, providing a more meaningful indicator of long-term health trajectory and disease risk.

This is why Dr Grosser combines advanced blood analysis with tools such as TruAge biological age testing. TruAge assesses how rapidly the body is ageing at a cellular level, providing insight into whether lifestyle factors, stress, inflammation, or metabolic imbalance are accelerating long-term risk, even when routine results appear reassuring.

This approach is not new, but it is becoming mainstream

While studies like the UK Biobank metabolomics project are now making headlines, the underlying concept is far from new. For Dr Konrad Grosser, systems-based assessment and early intervention have been central to his clinical work for many years.

As the only Functional Medicine Certified Interventional Cardiologist in the UK and Europe, Dr Grosser does not view health as a collection of isolated numbers. Instead, he focuses on how multiple biological systems interact over time. Using advanced diagnostics, he identifies early metabolic, hormonal, inflammatory, immune, and mitochondrial changes that conventional screening often overlooks.

In many ways, these pinprick blood test studies simply reinforce what functional medicine has been applying quietly in clinical practice: using detailed biological data to guide early, personalised intervention rather than waiting for disease to develop.

A consultation with Dr Konrad Grosser offers patients the opportunity to look beyond standard tests, understand their true health trajectory, and take meaningful action years before problems arise.

Your twenties might have felt like a blur of late nights, endless energy, and the comforting belief that your body could handle just about anything. However, as you reach your mid-30s, things begin to shift. The hangovers last longer, energy dips earlier, your jeans feel tighter, and the annual health check suddenly starts revealing numbers you’d rather not see.

A growing body of research shows that this turning point isn’t just coincidence, it’s biology. Both the number of risky health behaviours and the duration of exposure to them over time significantly increase the risk of later health problems.

The years of casual drinking, inconsistent sleep, poor diet, or sporadic exercise begin to leave their mark on your metabolism, hormones, and cardiovascular system. By the time you notice it, the changes may already be well underway.

A turning point

A Finnish study explored how risky lifestyle habits interact with long-term health outcomes. The researchers found that behaviours like heavy drinking, smoking, inactivity, and poor diet don’t just add up linearly, they multiply each other’s effects. Worse still, the longer these patterns persist, the harder they are to reverse.

Interestingly, the study also revealed the relationship is bidirectional. Poor health behaviours increase the risk of future health issues, but early metabolic problems such as rising blood sugar, elevated cholesterol, or inflammation, can also make people more likely to continue those same behaviours. In other words, once your body’s systems start to falter, your energy and motivation to make positive changes may drop, reinforcing the cycle.

This makes early diagnosis of metabolic risk factors critical. Detecting issues like insulin resistance or nutrient deficiencies at an early stage can act as a wake-up call, awakening what researchers describe as perceived susceptibility – where you start taking real ownership of your health.

Why your 30s are a metabolic crossroads

Your mid-30s are a unique biological window. Hormonal balance begins to change. Cortisol levels rise more easily, growth hormone and muscle mass naturally decline, and metabolic flexibility starts to wane. This means the same habits that felt harmless in your twenties like those extra drinks, skipped workouts, and late-night takeaways, begin to have measurable effects on blood sugar regulation, inflammation, and liver function.

This period also coincides with increasing life pressures like careers, families, and financial responsibilities. Stress becomes chronic, sleep quality suffers, and self-care often takes a backseat. It’s the perfect storm for metabolic dysfunction.

Through functional and cardiovascular testing, Dr Grosser evaluates markers such as fasting insulin, thyroid function, micronutrient status, and inflammation. These tests reveal how your lifestyle has been affecting your body long before disease sets in and, crucially, before symptoms become obvious.

Reclaiming your health

Your mid-30s mark the point where the cumulative effects of your choices start to show, but also where change can have its greatest impact. If you’ve been noticing shifts in your energy, weight, and mental clarity, or if you simply want to future-proof your health, now is the time to act.

When patients can see their biological data in black and white, it creates a powerful moment of awareness. And awareness is the spark for change.

Once the data is on the table, the focus shifts to restoring balance. This may include structured nutrition plans, exercise strategies that prioritise metabolic repair (like resistance training), and targeted supplementation to correct deficiencies.

In some cases, TruAge biological age testing can help track whether these interventions are truly reversing internal aging processes.

Book a consultation with Dr Konrad Grosser to assess your metabolic health and biological age. Understanding how your lifestyle has shaped your biology today is the first step to changing your tomorrow.